S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Critical asset just had biggest fall on record (Ad)
Stock market today: Wall Street clings to modest gains and marks another winning week
Dropbox’s stock is a falling knife worth catching
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Novavax’s dispute resolution and upcoming earnings call
Stock ideas from the 2024 Microcap Conference
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Warner Bros. Discover: Debt down, profits up, yet questions remain
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Critical asset just had biggest fall on record (Ad)
Stock market today: Wall Street clings to modest gains and marks another winning week
Dropbox’s stock is a falling knife worth catching
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Novavax’s dispute resolution and upcoming earnings call
Stock ideas from the 2024 Microcap Conference
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Warner Bros. Discover: Debt down, profits up, yet questions remain
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Critical asset just had biggest fall on record (Ad)
Stock market today: Wall Street clings to modest gains and marks another winning week
Dropbox’s stock is a falling knife worth catching
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Novavax’s dispute resolution and upcoming earnings call
Stock ideas from the 2024 Microcap Conference
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Warner Bros. Discover: Debt down, profits up, yet questions remain
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
Critical asset just had biggest fall on record (Ad)
Stock market today: Wall Street clings to modest gains and marks another winning week
Dropbox’s stock is a falling knife worth catching
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Novavax’s dispute resolution and upcoming earnings call
Stock ideas from the 2024 Microcap Conference
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Warner Bros. Discover: Debt down, profits up, yet questions remain

Verrica Pharmaceuticals (VRCA) Insider Trading & Ownership

$5.18
+0.07 (+1.37%)
(As of 02/23/2024 ET)

Verrica Pharmaceuticals (NASDAQ:VRCA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
41.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$8.94 M
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$471,200.18
Get VRCA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verrica Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRCA Insider Buying and Selling by Quarter


Verrica Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/28/2023Perceptive Advisors LlcMajor ShareholderBuy126,116$7.08$892,901.28  
12/26/2023Perceptive Advisors LlcMajor ShareholderBuy54,652$6.49$354,691.48  
12/21/2023Perceptive Advisors LlcMajor ShareholderBuy200,000$6.17$1,234,000.00  
12/18/2023Perceptive Advisors LlcMajor ShareholderBuy456,923$5.41$2,471,953.43  
12/15/2023Perceptive Advisors LlcMajor ShareholderBuy500,000$5.97$2,985,000.00  
11/14/2023Joe BonaccorsoInsiderSell21,580$2.93$63,229.40  
7/24/2023Christopher G HayesInsiderSell33,789$4.83$163,200.87  
7/24/2023Paul B ManningDirectorBuy200,000$5.02$1,004,000.00  
7/24/2023Ted WhiteCEOSell50,677$4.83$244,769.91  
(Data available from 1/1/2013 forward)












VRCA Insider Trading Activity - Frequently Asked Questions

Who is on Verrica Pharmaceuticals's Insider Roster?

The list of insiders at Verrica Pharmaceuticals includes A Brian Davis, Christopher G Hayes, Joe Bonaccorso, John A Stalfort III, Paul B Manning, Perceptive Advisors Llc, and Ted White. Learn more on insiders at VRCA.

What percentage of Verrica Pharmaceuticals stock is owned by insiders?

41.50% of Verrica Pharmaceuticals stock is owned by insiders. Learn more on VRCA's insider holdings.

Which Verrica Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased VRCA shares in the last 24 months: Christopher G Hayes ($37,499.40), John A Stalfort III ($499,999.50), Paul B Manning ($1,004,000.00), Perceptive Advisors Llc ($10,938,545.29), and Ted White ($49,998.90).

How much insider buying is happening at Verrica Pharmaceuticals?

Insiders have purchased a total of 3,241,380 VRCA shares in the last 24 months for a total of $12,530,043.09 bought.

Which Verrica Pharmaceuticals insiders have been selling company stock?

The following insiders have sold VRCA shares in the last 24 months: Christopher G Hayes ($163,200.87), Joe Bonaccorso ($63,229.40), and Ted White ($244,769.91).

How much insider selling is happening at Verrica Pharmaceuticals?

Insiders have sold a total of 106,046 Verrica Pharmaceuticals shares in the last 24 months for a total of $471,200.18 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:VRCA) was last updated on 2/24/2024 by MarketBeat.com Staff